Breast cancer is a disease that can affect anyone, of any gender, any age, and any demographic making it a truly hideous and terrifying disease. Groupon Founder Eric Lefkofsky is working to make breast cancer a thing of the past. Tempus, the cancer fighting startup that was founded by Lefkofsky is working to give doctors with University of Chicago a better chance at fighting breast cancer.Tempus announced earlier this week that they will partner with UChicago’s breast cancer specialist to help provide much needed molecular sequencing and analysis in order to create treatment plans that are tailored to the patient. Tempus is set to analyze data for 1,000 breast cancer patients in order to better ascertain patterns that might help to predict how a patient is going to respond to any one particular treatment plan.Lefkofsky is the cofounder of Tempus and has also founded companies like Lightbank, Groupon, Uptake Technologies and more. He works mainly in ventures that focus on data analytics and has been able to help apply knowledge to fight a number of causes.
In 2006 he started the Lefkofsky Family Foundation with his wife Liz to help advance high impact initiatives in surrounding communities. Lefkofsky is a Trustte at the Lurie Children’s Hospital of Chicago and works in a wide range of businesses and industries to better the world around us.The overall goal is to help to better tailor treatment for optimal patient outcome each time. “Although breast cancer is among the most common cancers, there is relatively little accessible data on the millions of patients who have battled the disease,” Dr. Olufunmilayo Olopade, professor of medicine and human genetics and Dean for Global Health at the University of Chicago, stated.
Tempus hopes to use machine learning and genomic sequencing to help doctors make real time decisions based around treatment for patients. Tempus was founded in 2015 and recently went public. Tempus is also partnering with the likes of Robert H. Laurie Comprehensive Cancer Center of Northwestern University as well as the Mayo Clinic. Their high profile partnerships do not end there as they also work with Rush University Medical Center, the University of Michigan, and Penn Medicine offering their services to provide data to help fight cancer. The partnership is still young but faith in the project is high.